ACCORD HLTHCARE FDA Approval ANDA 206252

ANDA 206252

ACCORD HLTHCARE

FDA Drug Application

Application #206252

Application Sponsors

ANDA 206252ACCORD HLTHCARE

Marketing Status

Prescription001

Application Products

001TABLET, EXTENDED RELEASE;ORALEQ 50MG BASE0QUETIAPINE FUMARATEQUETIAPINE FUMARATE

FDA Submissions

UNKNOWN; ORIG1AP2017-11-29STANDARD

Submissions Property Types

ORIG1Null15

TE Codes

001PrescriptionAB

CDER Filings

ACCORD HLTHCARE
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 206252
            [companyName] => ACCORD HLTHCARE
            [docInserts] => ["",""]
            [products] => [{"drugName":"QUETIAPINE FUMARATE","activeIngredients":"QUETIAPINE FUMARATE","strength":"EQ 50MG BASE","dosageForm":"TABLET, EXTENDED RELEASE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"11\/29\/2017","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2017-11-29
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.